Drugs / EN41-UGR7C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01827397 | Apr → Nov 2013 | HIV infectious disease | PX'Therapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EN41-UGR7C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01827397 ↗ |
| Modality | Vaccine | “EN41-UGR7C HIV vaccine” NCT01827397 ↗ |
| Route | Intramuscular | “Administered Intramuscularly” NCT01827397 ↗ |